John W. Eikelboom
Impact in
- Internal Medicine top 0.02%
- Venous Thromboembolism Diagnosis and Management
- Cardiology and Cardiovascular Medicine top 0.01%
- Atrial Fibrillation Management and Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
Papers in
-
- Atrial Fibrillation Management and Outcomes 310
- Antiplatelet Therapy and Cardiovascular Diseases 207
- Acute Myocardial Infarction Research 50
-
- Venous Thromboembolism Diagnosis and Management 131
- Co-authors
- Salim Yusuf (146 shared papers)Graeme J. Hankey (75 shared papers)Stuart J. Connolly (144 shared papers)Lars C. Wallentin (82 shared papers)Jeffrey Ian Weitz (60 shared papers)Michael D. Ezekowitz (52 shared papers)Paul A. Reilly (38 shared papers)Jonas Oldgren (52 shared papers)
- Journals
- Circulation (62 papers)European Heart Journal (53 papers)Journal of the American College of Cardiology (51 papers)Journal of Thrombosis and Haemostasis (43 papers)Thrombosis and Haemostasis (43 papers)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
John W. Eikelboom
835 papers receiving 71k citations
John W. Eikelboom's Hit Papers
Peers
Comparison fields: 5 of 181
- Internal Medicine 9.4k
- Cardiology and Cardiovascular Medicine 42.6k
- Hematology 6k
- Biochemistry 2.6k
- Critical Care and Intensive Care Medicine 858
Countries citing papers authored by John W. Eikelboom
This map shows the geographic impact of John W. Eikelboom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. Eikelboom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. Eikelboom more than expected).
Fields of papers citing papers by John W. Eikelboom
This network shows the impact of papers produced by John W. Eikelboom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. Eikelboom. The network helps show where John W. Eikelboom may publish in the future.
Co-authors
The 25 scholars most cited alongside John W. Eikelboom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 867 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dabigatran versus Warfarin in Patients with Atrial Fibrillation Hit paper breakdown → | 2009 | 8958 |
| 2 | Standardized Bleeding Definitions for Cardiovascular Clinical Trials Hit paper breakdown → | 2011 | 3752 |
| 3 | COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up Hit paper breakdown → | 2020 | 2275 |
| 4 | Apixaban in Patients with Atrial Fibrillation Hit paper breakdown → | 2011 | 1917 |
| 5 | Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease Hit paper breakdown → | 2017 | 1792 |
| 6 | Colchicine in Patients with Chronic Coronary Disease Hit paper breakdown → | 2020 | 1694 |
| 7 | Dabigatran versus Warfarin in Patients with Mechanical Heart Valves Hit paper breakdown → | 2013 | 1134 |
| 8 | Idarucizumab for Dabigatran Reversal Hit paper breakdown → | 2015 | 1133 |
| 9 | Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes Hit paper breakdown → | 2006 | 1078 |
| 10 | Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation Hit paper breakdown → | 2011 | 917 |
| 11 | Homocysteine and vascular disease Hit paper breakdown → | 1999 | 899 |
| 12 | Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events Hit paper breakdown → | 2002 | 879 |
| 13 | Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease Hit paper breakdown → | 2012 | 879 |
| 14 | Idarucizumab for Dabigatran Reversal — Full Cohort Analysis Hit paper breakdown → | 2017 | 852 |
| 15 | Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis Hit paper breakdown → | 2009 | 851 |
| 16 | Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial Hit paper breakdown → | 2010 | 810 |
| 17 | Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence Hit paper breakdown → | 1999 | 753 |
| 18 | Myocardial Injury after Noncardiac Surgery Hit paper breakdown → | 2014 | 735 |
| 19 | The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients Hit paper breakdown → | 2013 | 723 |
| 20 | Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range Hit paper breakdown → | 2008 | 716 |
About John W. Eikelboom
John W. Eikelboom is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine, Hematology, Biochemistry and Rheumatology, having authored 867 papers that have together received 75.2k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (310 papers), Antiplatelet Therapy and Cardiovascular Diseases (207 papers), Venous Thromboembolism Diagnosis and Management (131 papers), Blood Coagulation and Thrombosis Mechanisms (64 papers), Acute Myocardial Infarction Research (50 papers), Blood transfusion and management (32 papers), Folate and B Vitamins Research (29 papers) and Acute Ischemic Stroke Management (27 papers). The work is most often cited by research in Internal Medicine (9.4k citations), Cardiology and Cardiovascular Medicine (42.6k citations), Hematology (6k citations), Biochemistry (2.6k citations) and Critical Care and Intensive Care Medicine (858 citations). John W. Eikelboom has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Salim Yusuf, Graeme J. Hankey, Stuart J. Connolly, Lars C. Wallentin, Jeffrey Ian Weitz, Michael D. Ezekowitz, Paul A. Reilly, Jonas Oldgren, Jack Hirsh and Janice M. Pogue. Their work appears in journals such as Circulation, European Heart Journal, Journal of the American College of Cardiology, Journal of Thrombosis and Haemostasis and Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.